Oxford vaccine ‘70% effective’, may get India nod by year-end

Armed with interim findings of the AstraZeneca-Oxford Covid-19 vaccine trials — which showed 70% effectiveness in preventing people from getting infected — Pune-based Serum Institute of India (SII) is set to seek emergency regulatory approval and hopes to get a go-ahead by the year-end.

Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.

x